Andy is a Managing Director and the Global Head of Strategic Transactions at Locust Walk, where he advises life science companies on all forms of corporate transactions, including collaborations and M&A, whether as a buyer/licensor or seller/licensee. In addition, Andy is actively involved with the Locust Walk’s Capital Markets and Strategy and Analytics groups and has extensive experience advising life science companies across all aspects of their corporate development and executing high-value transactions. Prior to joining Locust Walk, Andy was an associate at Gunderson Dettmer, one of the nation’s leading business law firms for entrepreneurs, emerging growth companies and venture capitalists. Andy’s legal practice encompassed all areas of general corporate and securities law, with extensive experience in corporate financings, including public and private offerings of equity and debt, licensing transactions and mergers and acquisitions. Andy also represented life sciences companies in all stages of their lifecycles, from start-ups to public companies. Andy was also previously an associate in the Corporate and Financial Services group at Willkie Farr & Gallagher. Andy holds a MBA from New York University Stern School of Business, a JD from New York University School of Law and a BSE in Biomedical and Electrical Engineering from Duke University.